Bone Mineral Density and Breast Cancer Risk in Postmenopausal Women

Bone mineral density (BMD) is widely recognised as a marker of skeletal health in postmenopausal women, reflecting cumulative exposure to oestrogen and other endocrine factors. Epidemiological studies have revealed a paradox: higher BMD, which indicates greater oestrogenic stimulation of bone formation, is frequently associated with an elevated risk of oestrogen receptor-positive breast cancer. This association is thought to arise from shared hormonal pathways that promote both bone accretion and mammary epithelial proliferation. Assessment of BMD by dual-energy X-ray absorptiometry (DXA) yields T scores and Z scores that capture deviations from peak bone mass and age-matched norms respectively. Beyond static measures, bone turnover markers offer dynamic insights into remodelling rates, although their predictive role in primary breast cancer risk remains under investigation. Genetic factors, body mass index and the use of hormone replacement therapy modulate the relationship between BMD and tumour initiation. Clinically, the integration of BMD into multifactorial risk models has potential to refine stratification strategies for breast cancer screening and prevention. Lifestyle interventions and selective oestrogen receptor modulators that preserve bone density while limiting breast epithelial proliferation represent an emerging area of translational research. Understanding the bidirectional links between bone metabolism and breast oncogenesis carries global significance, informing both fracture prevention and cancer risk reduction in ageing populations.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Bone Mineral Density and Breast Cancer Risk in Postmenopausal Women publication trend

The graph below shows the total number of articles in bone mineral density and breast cancer risk in postmenopausal women across all publications each year (not limited to Nature Index journals).

Technical terms

Bone Mineral Density (BMD): A quantitative measure of mineral content in bone, expressed in grams per square centimetre, indicative of bone strength and fracture risk.

Dual-energy X-ray Absorptiometry (DXA): A non-invasive imaging modality that uses two X-ray beams at different energies to assess BMD at axial and peripheral skeletal sites.

T score: A standardised score comparing an individual’s BMD to the mean peak BMD of a healthy young adult reference population; used to diagnose osteoporosis.

Z score: A standardised score comparing an individual’s BMD to the mean BMD of an age- and sex-matched population; useful for identifying atypical bone density relative to peers.

References

1. Bone mineral density in women newly diagnosed with breast cancer: a prospective cohort study. npj Breast Cancer (2022).
2. Association between Bone Mineral Density and Incidence of Breast Cancer. PLOS ONE (2013).